SCLN Financial Facts

General and administrative: 7.29M
Provision for income tax: 587K
See Full Income Statement

Total liabilities and stockholders' equity: 202.23M
Inventories: 12.15M
See Full Balance Sheet

SciClone Pharmaceuticals, Inc. (SCLN) Earnings

  |   Expand Research on SCLN
Next EPS Date 2/10/16 *Est. EPS Growth Rate +35.3% *Last Qtr.
Average EPS % Beat Rate +197.9% Revenue Growth Rate +25.1% *Last Qtr.
Average % Move 1-Wk after EPS +8.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/9/15 Q315 $0.23N/A N/A $42.9M$34.3M N/A Details
8/10/15 Q215 $0.26$0.12 +$0.14$37.9M$37.27M N/A Details
5/11/15 Q115 $0.19$0.03 +$0.16$33.6M$34M N/A Details
11/10/14 Q314 $0.17$0.12 +$0.05$34.3M$34.9M Details
8/11/14 Q214 $0.20$0.10 +$0.10$32.5M$33.4M Details
5/12/14 Q114 $0.10$0.08 +$0.02$26.6M$32.2M Details
4/1/13 Q413 $0.04$0.12 -$0.08$33.1M$35.3M Details
3/12/14 Q413 $0.08$0.15 -$0.07$32.7M$38.3M Details